Nasal vaccination using live bacterial vectors (Q34343251)

1 August 2017

title

Nasal vaccination using live bacterial vectors (English)

1 reference

1 August 2017

Mielcarek N

1

1 reference

1 August 2017

Alonso S

series ordinal

2

1 reference

1 August 2017

Locht C

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Advanced Drug Delivery Reviews

1 August 2017

published in

1 reference

1 August 2017

volume

51

1 reference

1 August 2017

issue

1-3

1 reference

1 August 2017

page(s)

55-69

1 reference

A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Use of green fluorescent protein to tag lactic acid bacterium strains under development as live vaccine vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Survival, physiology, and lysis of Lactococcus lactis in the digestive tract

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Chromosomal integration of the green fluorescent protein gene in lactic acid bacteria and the survival of marked strains in human gut simulations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Oral vaccination of mice against tetanus with recombinant Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Lactic acid bacteria as vaccine delivery vehicles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Recombinant Gram-positive bacteria as vehicles of vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Vaginal immunization with recombinant gram-positive bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Production of cholera toxin B subunit in Lactobacillus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Efficient secretion of the model antigen M6-gp41E in Lactobacillus plantarum NCIMB 8826

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Immunoadjuvant activity of oralLactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Antibiotic Resistance Genes in Coagulase-negative Staphylococci Isolated from Food

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Effect of proteolytic starter cultures of Staphylococcus spp. on biogenic amine formation during the ripening of dry fermented sausages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Molecular and physiological characterization of dominant bacterial populations in traditional mozzarella cheese processing

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Isolation and Characterization of Staphylococci from Human Skin I. Amended Descriptions of Staphylococcus epidermidis and Staphylococcus saprophyticus and Descriptions of Three New Species: Staphylococcus cohnii, Staphylococcus haemolyticus, and S...

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Acute pyelonephritis caused by Staphylococcus xylosus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Endocarditis caused by Staphylococcus xylosus associated with intravenous drug abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Engineering of a Staphylococcus carnosus surface display system by substitution or deletion of a Staphylococcus hyicus lipase propeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Expression of recombinant proteins on the surface of the coagulase-negative bacterium Staphylococcus xylosus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Cell surface display of recombinant proteins on Staphylococcus carnosus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Recombinant Staphylococcus strains as live vectors for the induction of neutralizing anti-diphtheria toxin antisera.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Cell-surface display of heterologous epitopes on Staphylococcus xylosus as a potential delivery system for oral vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Surface display of the cholera toxin B subunit on Staphylococcus xylosus and Staphylococcus carnosus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Surface display of functional fibronectin-binding domains on Staphylococcus carnosus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

A surface-displayed cholera toxin B peptide improves antibody responses using food-grade staphylococci for mucosal subunit vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Carriage of Neisseria meningitidis and Neisseria lactamica in Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Immunization of mice by oral colonization with live recombinant commensal streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Streptococci of Dental Plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Live attenuated Salmonella: a paradigm of mucosal vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Construction and characterization of a Salmonella enterica serovar typhimurium clone expressing a salivary adhesin of Streptococcus mutans under control of the anaerobically inducible nirB promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

A lethal role for lipid A in Salmonella infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Surface-displayed viral antigens on Salmonella carrier vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Induction of a local anti-IpaC antibody response in mice by use of a Shigella flexneri 2a vaccine candidate: implications for use of IpaC as a protein carrier

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

DeltaguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

New use of BCG for recombinant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

BCG Expressing LCR1 of Leishmania chagasi Induces Protective Immunity in Susceptible Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Long-lasting protective immunity against rodent malaria parasite infection at the blood stage by recombinant BCG secreting merozoite surface protein-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

A new series of mycobacterial expression vectors for the development of live recombinant vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Aerogenic BCG vaccination against tuberculosis in animal and human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing glutathione S-transferase from Schistosoma haematobium

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Recombinant bacille Calmette-Guérin expressing the measles virus nucleoprotein protects infant rhesus macaques from measles virus pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

The filamentous haemagglutinin, a multifaceted adhesion produced by virulent Bordetella spp.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Local transient induction of inflammatory cytokines after intranasal administration of recombinantBordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Responses to Bordetella pertussis mutant strains and to vaccination in the coughing rat model of pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

Live bacterial vectors for intranasal delivery of protective antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900168-5

7 January 2021

10.1016/S0169-409X(01)00168-5

Identifiers

DOI

1 reference

1 August 2017

1 reference